ARCHIVES

NCI Advisory Group, Other Cancer Meetings

This article is from The Cancer Letter archive.

Vol. 13 No. 22 | May 29, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi

July 3, 1992

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998